QQQ   268.93 (-0.51%)
AAPL   108.70 (-1.49%)
MSFT   201.55 (-0.67%)
FB   254.88 (+0.02%)
GOOGL   1,477.86 (-0.62%)
AMZN   2,987.82 (-0.69%)
NVDA   492.68 (-1.18%)
TSLA   443.59 (+4.76%)
BABA   273.71 (-0.73%)
CGC   16.37 (-0.18%)
GE   7.08 (+0.43%)
MU   51.73 (+1.47%)
AMD   75.52 (-1.35%)
T   29.16 (+0.31%)
F   7.36 (+1.10%)
ACB   6.75 (-2.03%)
GILD   64.76 (-0.43%)
NFLX   471.61 (+0.30%)
DIS   129.63 (-0.45%)
BAC   25.49 (+0.55%)
BA   168.35 (+0.49%)
QQQ   268.93 (-0.51%)
AAPL   108.70 (-1.49%)
MSFT   201.55 (-0.67%)
FB   254.88 (+0.02%)
GOOGL   1,477.86 (-0.62%)
AMZN   2,987.82 (-0.69%)
NVDA   492.68 (-1.18%)
TSLA   443.59 (+4.76%)
BABA   273.71 (-0.73%)
CGC   16.37 (-0.18%)
GE   7.08 (+0.43%)
MU   51.73 (+1.47%)
AMD   75.52 (-1.35%)
T   29.16 (+0.31%)
F   7.36 (+1.10%)
ACB   6.75 (-2.03%)
GILD   64.76 (-0.43%)
NFLX   471.61 (+0.30%)
DIS   129.63 (-0.45%)
BAC   25.49 (+0.55%)
BA   168.35 (+0.49%)
QQQ   268.93 (-0.51%)
AAPL   108.70 (-1.49%)
MSFT   201.55 (-0.67%)
FB   254.88 (+0.02%)
GOOGL   1,477.86 (-0.62%)
AMZN   2,987.82 (-0.69%)
NVDA   492.68 (-1.18%)
TSLA   443.59 (+4.76%)
BABA   273.71 (-0.73%)
CGC   16.37 (-0.18%)
GE   7.08 (+0.43%)
MU   51.73 (+1.47%)
AMD   75.52 (-1.35%)
T   29.16 (+0.31%)
F   7.36 (+1.10%)
ACB   6.75 (-2.03%)
GILD   64.76 (-0.43%)
NFLX   471.61 (+0.30%)
DIS   129.63 (-0.45%)
BAC   25.49 (+0.55%)
BA   168.35 (+0.49%)
QQQ   268.93 (-0.51%)
AAPL   108.70 (-1.49%)
MSFT   201.55 (-0.67%)
FB   254.88 (+0.02%)
GOOGL   1,477.86 (-0.62%)
AMZN   2,987.82 (-0.69%)
NVDA   492.68 (-1.18%)
TSLA   443.59 (+4.76%)
BABA   273.71 (-0.73%)
CGC   16.37 (-0.18%)
GE   7.08 (+0.43%)
MU   51.73 (+1.47%)
AMD   75.52 (-1.35%)
T   29.16 (+0.31%)
F   7.36 (+1.10%)
ACB   6.75 (-2.03%)
GILD   64.76 (-0.43%)
NFLX   471.61 (+0.30%)
DIS   129.63 (-0.45%)
BAC   25.49 (+0.55%)
BA   168.35 (+0.49%)
Log in
NYSE:XAN

Exantas Capital Stock Forecast, Price & News

$2.16
+0.03 (+1.41 %)
(As of 09/18/2020 10:37 AM ET)
Add
Compare
Today's Range
$2.14
Now: $2.16
$2.16
50-Day Range
$2.09
MA: $2.35
$2.65
52-Week Range
$0.95
Now: $2.16
$12.51
Volume136 shs
Average Volume1.17 million shs
Market Capitalization$69.28 million
P/E RatioN/A
Dividend YieldN/A
Beta1.32
Exantas Capital Corp., a real estate investment trust, primarily focuses on the origination, holding, and management of commercial mortgage loans and commercial real estate-related debt investments in the United States. It invests in commercial real estate-related assets, including first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine debt, preferred equity investments related to commercial real estate (CRE), commercial mortgage-backed securities, and CRE equity investments. The company qualifies as a real estate investment trust (REIT) for federal income tax purposes. It generally would not be subject to federal corporate income tax to the extent that it distributes 100% of its REIT taxable income. The company was formerly known as Resource Capital Corp. and changed its name to Exantas Capital Corp. in May 2018. Exantas Capital Corp. was founded in 2005 and is based in New York, New York.
Read More
Exantas Capital logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.48 out of 5 stars


Industry, Sector and Symbol

Industry Real estate investment trusts
Sub-IndustryN/A
SectorFinance
CUSIPN/A
CIKN/A
Phone516-535-0015

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$61.15 million
Cash Flow$1.52 per share
Book Value$17.45 per share

Profitability

Net Income$35.97 million
Net Margins-347.93%

Miscellaneous

EmployeesN/A
Market Cap$69.28 million
Next Earnings Date11/4/2020 (Estimated)
OptionableOptionable
$2.16
+0.03 (+1.41 %)
(As of 09/18/2020 10:37 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive XAN News and Ratings via Email

Sign-up to receive the latest news and ratings for XAN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Exantas Capital (NYSE:XAN) Frequently Asked Questions

How has Exantas Capital's stock been impacted by COVID-19 (Coronavirus)?

Exantas Capital's stock was trading at $9.75 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, XAN stock has decreased by 77.8% and is now trading at $2.16.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Exantas Capital?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exantas Capital in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Exantas Capital
.

When is Exantas Capital's next earnings date?

Exantas Capital is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Exantas Capital
.

How were Exantas Capital's earnings last quarter?

Exantas Capital Corp (NYSE:XAN) posted its quarterly earnings results on Thursday, May, 7th. The company reported $0.23 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.30 by $0.07. The company earned $14.90 million during the quarter. Exantas Capital had a negative net margin of 347.93% and a positive return on equity of 8.10%.
View Exantas Capital's earnings history
.

How often does Exantas Capital pay dividends? What is the dividend yield for Exantas Capital?

Exantas Capital declared a quarterly dividend on Friday, March 13th. Stockholders of record on Tuesday, March 31st will be given a dividend of $0.275 per share on Tuesday, April 28th. This represents a $1.10 annualized dividend and a yield of 50.93%. The ex-dividend date is Monday, March 30th.
View Exantas Capital's dividend history
.

What price target have analysts set for XAN?

2 brokerages have issued 12-month price targets for Exantas Capital's shares. Their forecasts range from $4.00 to $4.00. On average, they expect Exantas Capital's share price to reach $4.00 in the next year. This suggests a possible upside of 85.2% from the stock's current price.
View analysts' price targets for Exantas Capital
.

Are investors shorting Exantas Capital?

Exantas Capital saw a decline in short interest in the month of August. As of August 31st, there was short interest totaling 1,200,000 shares, a decline of 14.3% from the August 15th total of 1,400,000 shares. Based on an average trading volume of 1,050,000 shares, the short-interest ratio is currently 1.1 days. Approximately 3.9% of the company's stock are short sold.
View Exantas Capital's Short Interest
.

Who are some of Exantas Capital's key competitors?

What other stocks do shareholders of Exantas Capital own?

Who are Exantas Capital's key executives?

Exantas Capital's management team includes the following people:
  • Mr. Robert C. Lieber, Chief Exec. Officer (Age 65)
  • Mr. Matthew J. Stern, Pres (Age 45)
  • Mr. David J. Bryant, Sr. VP, CFO & Treasurer (Age 61)
  • Mr. Thomas C. Elliott, Exec. VP of Fin. & Operations (Age 46)
  • Mr. Eldron C. Blackwell, VP & Chief Accounting Officer (Age 40)

What is Exantas Capital's stock symbol?

Exantas Capital trades on the New York Stock Exchange (NYSE) under the ticker symbol "XAN."

Who are Exantas Capital's major shareholders?

Exantas Capital's stock is owned by many different institutional and retail investors. Top institutional shareholders include LSV Asset Management (2.53%), WINTON GROUP Ltd (1.71%), Two Sigma Advisers LP (1.00%), Jane Street Group LLC (0.72%), Prudential Financial Inc. (0.55%) and Orinda Asset Management LLC (0.53%). Company insiders that own Exantas Capital stock include David J Bryant, Robert C Lieber and Thomas C Elliott.
View institutional ownership trends for Exantas Capital
.

Which major investors are selling Exantas Capital stock?

XAN stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Bank of New York Mellon Corp, Ancora Advisors LLC, Charles Schwab Investment Management Inc., Advisor Group Holdings Inc., Orinda Asset Management LLC, LSV Asset Management, and Bank of America Corp DE.
View insider buying and selling activity for Exantas Capital
.

Which major investors are buying Exantas Capital stock?

XAN stock was purchased by a variety of institutional investors in the last quarter, including WINTON GROUP Ltd, Jane Street Group LLC, Prudential Financial Inc., Clearwater Capital Advisors LLC, Two Sigma Advisers LP, Leap Investments LP, Eidelman Virant Capital, and Principal Financial Group Inc.. Company insiders that have bought Exantas Capital stock in the last two years include David J Bryant, Robert C Lieber, and Thomas C Elliott.
View insider buying and selling activity for Exantas Capital
.

How do I buy shares of Exantas Capital?

Shares of XAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Exantas Capital's stock price today?

One share of XAN stock can currently be purchased for approximately $2.16.

How big of a company is Exantas Capital?

Exantas Capital has a market capitalization of $69.28 million and generates $61.15 million in revenue each year. The company earns $35.97 million in net income (profit) each year or $1.00 on an earnings per share basis.

What is Exantas Capital's official website?

The official website for Exantas Capital is www.exantas.com.

How can I contact Exantas Capital?

Exantas Capital's mailing address is 865 MERRICK AVENUE, NEW YORK NY, 11590. The company can be reached via phone at 516-535-0015 or via email at [email protected]

This page was last updated on 9/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.